WHO ICTRP trial
Effect of pioglitazone on asthmatic patients
IRCT201112268528N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201112268528N1 |
|---|---|
| Public title | Effect of pioglitazone on asthmatic patients |
| Scientific title | Effect of pioglitazone on clinical response' pulmonary function and Inflammatory biomarkers in asthmatic patients |
| Primary sponsor | Kermanshah University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 0 (exploratory trials) |
| Countries | Iran (Islamic Republic of) |
| Conditions | Asthma. Asthmatic bronchitis NOS Late-onset asthma;Asthmatic bronchitis NOS Late-onset asthma |
| Interventions | Intervention 1: Intervention group: 30 milligram of pioglitazone tablet will be given once daily for two months orally to the patients in the intervention group. Intervention 2: Control group: 30 milligram of placebo tablet will be given… |
| Registration date | Apr 16, 2012 |
| Target size | 45 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: